Terrestrial Bio, Inc.
Last verified 2026-05-08. JSON
| Total raised | $57.3M |
|---|---|
| Latest round | Funding round, $57.3M, 2026-03-19 |
| Founded | unknown |
| Headquarters | WOBURN, MA |
| Industry | bio |
| Stage | unknown |
| Website | terrestrialbio.com |
Terrestrial develops the Tacterra microarray patch, a needle-free drug delivery system using dissolvable tips made from advanced biomaterials. It serves patients needing injectable therapies such as GLP-1 treatments who want at-home self-administration.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-03-19 | Funding round | $57.3M | undisclosed |
Detected tech stack
Typekit, Adobe Fonts, Afterpay, Sentry, Spin.js, Squarespace, Squarespace Commerce, Stimulus, parallax.js, web-vitals, moment 0, @sentry/browser
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $57.3M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $57.3M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | terrestrialbio.com, read 2026-05-08 |
| Description | self-reported | terrestrialbio.com, read 2026-05-08 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $57.3M, 2026-03-19 → Funding round, $57.3M, 2026-03-19, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $57.3M, 2026-03-19 → Funding round, $57.3M, 2026-03-19 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes